Clinical Challenges

Care of the Open Abdomen After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies

Deena Damsky Dell

Jeanne Held-Warmkessel

Pamela R. Jakubek

Tina O'Mara

cytoreductive, hyperthermic intraperitoneal chemotherapy, surgery
ONF 2014, 41(4), 438-441. DOI: 10.1188/14.ONF.438-441

A patient with a mucinous appendiceal cancer presents to the surgeon complaining of abdominal discomfort and nausea. Having undergone a prior right hemicolectomy, the patient has been disease free and on surveillance with clinical and carcinogenic antigen (CEA) monitoring. The CEA was noted to be elevated and a computed tomography scan revealed peritoneal nodules throughout the abdomen with a presumptive diagnosis of pseudomyxoma peritonei (progressive peritoneal implants from a mucinous primary). Several therapeutic options were offered and the patient selected to undergo cytoreductive surgery (CRS) with the potential to receive hyperthermic interoperative chemotherapy (HIPEC). Extensive resection was performed, including removal of the entire greater omentum, partial gastrectomy, and total pelvic exenteration with end colostomy and ileal conduit. Reassessment of the peritoneal cavity after the resections revealed almost complete cytoreduction. HIPEC was performed with mitomycin C and, after drainage and abdominal washing, the intestinal segments were anastomosed and the abdominal wall closed. Seven days postoperatively, an acute abdomen with septic shock developed as a result of a leak from the ileocolonic anastomosis. The patient returned to the operating room and an exploratory laparotomy, a small bowel resection, a resection of the ileocolonic anastomosis, and an abdominal washout were performed. Edema of the bowel caused by peritonitis resulting from the anastomotic leak necessitated delayed closure of the abdominal wall. A temporary abdominal closure using the ABThera™ Open Abdomen Negative Pressure Therapy system was applied and the abdomen was eventually closed.

Jump to a section


    Cooksley, T., & Haji-Michael, P. (2011). Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). World Journal of Clinical Oncology, 9, 169.
    de Bree, E., & Helm, C. W. (2012). Hyperthermic intraperitoneal chemotherapy in ovarian cancer: Rational and clinical data. Expert Reviews in Anticancer Therapy, 12, 895-911.
    de Bree, E., & Tsiftsis, D. D. (2007a). Experimental and pharmacokinetic studies in intraperitoneal chemotherapy: From laboratory bench to bedside. Recent Results in Cancer Research, 169, 53-73.
    de Bree, E., & Tsiftsis, D. D. (2007b). Principles of perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis. Recent Results in Cancer Research, 169, 39-51.
    Demetrios, D. (2012). Total management of the open abdomen. International Wound Journal, 9(Suppl. 1), 17-24.
    Demetrios, D., & Salim, A. (2014). Management of the open abdomen. Surgical Clinics of North America, 94, 131-153. doi:10.1016/j.suc.2013.10.010
    Elias, D., Gilly, F., Boutitie, F., Quenet, F., Bereder, J. M., Mansvelt, B., … Glehen, O. (2010). Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: Retrospective analysis of 523 patients from a multicentric French study. Journal of Clinical Oncology, 28, 63-68.
    Elias, D., Lefevre, J. H., Chevalier, J., Brouquet, A., Marchal, F., Classe, J. M., … Bonastre, J. (2009). Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. Journal of Clinical Oncology, 27, 681-685. doi:10.1200/JCO.2008.19.7160
    Franklin, M. E., Alvarez, A., & Russek, K. (2012). Negative pressure therapy: A viable option for general surgical management of the open abdomen. Surgical Innovation, 19, 353-363. doi:10.1177/1553350611429693
    Gonzalez-Moreno, S., Gonzalez-Bayon, L. A., & Ortega-Perez, G. (2010). Hyperthermic intraperitoneal chemotherapy: Rationale and technique. World Journal of Gastrointestinal Oncology, 2(2), 68-75.
    Gonzalez-Moreno, S., Gonzalez-Bayon, L. A., & Ortega-Perez, G. (2012). Hyperthermic intraperitoneal chemotherapy methodology and safety considerations. Surgical Oncology Clinics of North America, 21, 543-557. doi:10.1016/j.soc .2012.07.001
    Helm, C. (2012). Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer. Surgical Oncology Clinics of North America, 21, 645-663. doi:10.1016/j.soc .2012.07.007
    Mendez-Eastman, S. (2006). Vacuum assisted closure advanced therapy system troubleshooting guide. Plastic Surgical Nursing, 26, 37-39.
    Quyn, A. J., Johnston, C., Hall, D., Chambers, A., Arapova, N., Ogston S., & Amin, A. I. (2012). The open abdomen and temporary abdominal closure systems-historical evolution and systematic review. Colorectal Disease, 14, 429-438.
    Turza, K. C., Campbell, C. A., Rosenberger, L. H., Politano, A. D., Davies, S. W., Ricio, L. M., & Sawyer, R. G. (2012). Options for closure of the infected abdomen. Surgical Infections, 13, 343-351.
    Witkamp, A. J., de Bree, E., Van Goethem, A. R., & Zoetmulder, F. A. (2001). Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treatment Reviews, 27, 365-374.
    Wooten, L. (2009). Appendix B: Nursing care of the HIPEC patient. Current Problems in Cancer, 33, 227-237. doi:10/1016/j.currproblcancer.2009.06.007
    Yan, T., Black, D., Savady, R., & Sugarbaker, P. (2006). Systemic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. Journal of Clinical Oncology, 24, 4011-4019. doi:10.1200/JCO.2006.07.1142